Fatigue News and Research

RSS

Saliva testing has high accuracy in detecting early cases of SARS-CoV-2

New research finds saliva testing has a high sensitivity for detecting severe acute respiratory syndrome 2 (SARS-CoV-2) in both symptomatic and asymptomatic patients.

7 Mar 2021

Study shows potential benefits from meditation-based teacher development program

Teachers who participated in a meditation-based teacher development program utilizing the Transcendental Meditation (TM) technique for four months, had significant improvements in emotional exhaustion (the leading factor in burnout), resilience, perceived stress, fatigue, and depression according to a new randomized controlled trial published today in Frontiers in Education.

5 Mar 2021

Psychiatric and cognitive problems in large number of COVID-19 survivors

A research review led by Oxford Brookes University has found a large proportion of COVID-19 survivors will be affected by neuropsychiatric and cognitive complications.

4 Mar 2021

Coronavirus deranges the immune system in complex and deadly ways

There's a reason soldiers go through basic training before heading into combat: Without careful instruction, green recruits armed with powerful weapons could be as dangerous to one another as to the enemy.

4 Mar 2021

COVID-19 pandemic had major impacts on childhood cancer care, shows survey

The COVID-19 pandemic has had major impacts on childhood cancer care worldwide, according to a survey of more than 300 clinicians from 200 hospitals worldwide published in The Lancet Child & Adolescent Health journal.

3 Mar 2021

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Novavax, Inc., the American vaccine development company, has been developing a recombinant protein nanoparticle COVID-19 vaccine currently termed NVX-CoV2373. The full-length spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is created in a baculovirus vector, which is then inserted into a lipid nanoparticle around 50 nm in diameter.

3 Mar 2021

Study demonstrates long-term neuropsychological consequences following SARS-CoV-2 infection

The study, published in the pre-print server medRxiv, demonstrates the presence of long-lasting neuropsychological sequelae after COVID-19, regardless of the respiratory disease's severity.

2 Mar 2021

Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies

A thought-provoking new study server discusses the factors that determine the successful use of available vaccines to mitigate incidence and mortality rates for COVID-19.

2 Mar 2021

Researchers focus on the role of human behavior to advance comfort knowledge

Comfort is a daily human experience central to the perception of our environment and the continuous processing of sensory input.

2 Mar 2021

FDA issues EUA for third COVID-19 vaccine

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

1 Mar 2021

New open-source platform can advance research on atrial fibrillation

An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterized by an irregular and often fast heartbeat.

27 Feb 2021

Researchers use new approaches to address premature failure of dental restorations

How can dental restorations - such as fillings and crowns - be made to last longer? A new research group centered at Charité - Universitätsmedizin Berlin and Technische Universität (TU) Berlin plans to address this topic by utilizing approaches from both materials science and dentistry.

27 Feb 2021

Learning to live again: A Lazarus tale from the Covid front lines

The twinkle in his eyes, the delight in his smile, the joyous way he moved his disease-withered frame. They all proclaimed a single, resounding message: Grateful to be alive!

26 Feb 2021

Virtual reality program reduces treatment-related side effects in hemodialysis patients

Hemodialysis patients routinely experience side effects such as fatigue, lightheadedness and nausea during their treatment sessions.

25 Feb 2021

AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

A new study provides a timely answer to many of these fears, by reporting on the results of an analysis of over 31,000 vaccine recipients with respect to immediate adverse effects, reported within 21 days, of the first and/or second doses of the vaccine.

25 Feb 2021

SARS-CoV-2 does not infect the entire body in the same way, finds study

COVID-19, the disease caused by the pandemic coronavirus SARS-CoV-2, is primarily regarded as a respiratory infection. Yet the virus has also become known for affecting other parts of the body in ways not as well understood, sometimes with longer-term consequences, such as heart arrhythmia, fatigue and "brain fog."

24 Feb 2021

COVID-19 may alter host proteins to cause autoimmunity

To better understand the transient and chronic autoimmune symptoms caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, researchers from Memorial Sloan Kettering Cancer Center, Guizhou Medical University, and biotech company Curandis embarked on an endeavor to establish a comprehensive autoantigenome for COVID19.

23 Feb 2021

TBE patients continue to be affected by long-term problems

Impaired memory, reduced motivation, and declining motor skills. These are some of the problems that may persist several years after people contract tick-borne encephalitis, a University of Gothenburg thesis shows.

23 Feb 2021

Virus-specific cellular immunity may be essential for long-term protection against SARS-CoV-2

Researchers from China and the US recently synthesized select peptide pools of the structural and functional proteins of SARS-CoV-2, including spike (S), envelope (E), membrane (M), nucleocapsid (N), and protease (P) proteins as target antigens to assess COVID-19-specific immunity.

22 Feb 2021

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.

19 Feb 2021

Fatigue News and Research

Saliva testing has high accuracy in detecting early cases of SARS-CoV-2

Study shows potential benefits from meditation-based teacher development program

Psychiatric and cognitive problems in large number of COVID-19 survivors

Coronavirus deranges the immune system in complex and deadly ways

COVID-19 pandemic had major impacts on childhood cancer care, shows survey

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Study demonstrates long-term neuropsychological consequences following SARS-CoV-2 infection

Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies

Researchers focus on the role of human behavior to advance comfort knowledge

FDA issues EUA for third COVID-19 vaccine

New open-source platform can advance research on atrial fibrillation

Researchers use new approaches to address premature failure of dental restorations

Learning to live again: A Lazarus tale from the Covid front lines

Virtual reality program reduces treatment-related side effects in hemodialysis patients

AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

SARS-CoV-2 does not infect the entire body in the same way, finds study

COVID-19 may alter host proteins to cause autoimmunity

TBE patients continue to be affected by long-term problems

Virus-specific cellular immunity may be essential for long-term protection against SARS-CoV-2

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News